nodes	percent_of_prediction	percent_of_DWPC	metapath
Epirubicin—ABCC1—Cyclosporine—focal segmental glomerulosclerosis	0.505	1	CbGbCtD
Epirubicin—Heart sounds abnormal—Cyclosporine—focal segmental glomerulosclerosis	0.026	0.0698	CcSEcCtD
Epirubicin—Abnormal pigmentation—Cyclosporine—focal segmental glomerulosclerosis	0.023	0.0617	CcSEcCtD
Epirubicin—CHD1—nephron tubule—focal segmental glomerulosclerosis	0.0147	0.167	CbGeAlD
Epirubicin—CHD1—cortex of kidney—focal segmental glomerulosclerosis	0.0126	0.143	CbGeAlD
Epirubicin—AURKA—kidney—focal segmental glomerulosclerosis	0.0104	0.118	CbGeAlD
Epirubicin—DHCR7—nephron tubule—focal segmental glomerulosclerosis	0.00989	0.112	CbGeAlD
Epirubicin—Septicemia—Cyclosporine—focal segmental glomerulosclerosis	0.00955	0.0256	CcSEcCtD
Epirubicin—DHCR7—cortex of kidney—focal segmental glomerulosclerosis	0.00846	0.0962	CbGeAlD
Epirubicin—YWHAG—kidney—focal segmental glomerulosclerosis	0.00797	0.0906	CbGeAlD
Epirubicin—YWHAG—cortex of kidney—focal segmental glomerulosclerosis	0.00777	0.0882	CbGeAlD
Epirubicin—UGT2B7—kidney—focal segmental glomerulosclerosis	0.0072	0.0818	CbGeAlD
Epirubicin—Polyneuropathy—Cyclosporine—focal segmental glomerulosclerosis	0.00665	0.0179	CcSEcCtD
Epirubicin—Pigmentation disorder—Cyclosporine—focal segmental glomerulosclerosis	0.0065	0.0174	CcSEcCtD
Epirubicin—Doxorubicin—NOS2—focal segmental glomerulosclerosis	0.00631	1	CrCbGaD
Epirubicin—PLA2G4A—cortex of kidney—focal segmental glomerulosclerosis	0.00579	0.0658	CbGeAlD
Epirubicin—Bullous eruption—Cyclosporine—focal segmental glomerulosclerosis	0.00549	0.0147	CcSEcCtD
Epirubicin—Leukorrhea—Cyclosporine—focal segmental glomerulosclerosis	0.00462	0.0124	CcSEcCtD
Epirubicin—Myositis—Cyclosporine—focal segmental glomerulosclerosis	0.00442	0.0119	CcSEcCtD
Epirubicin—Urine abnormality—Cyclosporine—focal segmental glomerulosclerosis	0.00392	0.0105	CcSEcCtD
Epirubicin—Gingival bleeding—Cyclosporine—focal segmental glomerulosclerosis	0.00382	0.0103	CcSEcCtD
Epirubicin—Gastric ulcer—Cyclosporine—focal segmental glomerulosclerosis	0.00373	0.01	CcSEcCtD
Epirubicin—Urine analysis abnormal—Cyclosporine—focal segmental glomerulosclerosis	0.00369	0.0099	CcSEcCtD
Epirubicin—Polyp—Cyclosporine—focal segmental glomerulosclerosis	0.00356	0.00957	CcSEcCtD
Epirubicin—Vaginal discharge—Cyclosporine—focal segmental glomerulosclerosis	0.00356	0.00957	CcSEcCtD
Epirubicin—Serum creatinine increased—Cyclosporine—focal segmental glomerulosclerosis	0.00353	0.00946	CcSEcCtD
Epirubicin—Optic neuritis—Cyclosporine—focal segmental glomerulosclerosis	0.00353	0.00946	CcSEcCtD
Epirubicin—Folliculitis—Cyclosporine—focal segmental glomerulosclerosis	0.00345	0.00926	CcSEcCtD
Epirubicin—Psoriasis—Cyclosporine—focal segmental glomerulosclerosis	0.00345	0.00926	CcSEcCtD
Epirubicin—Hypomagnesaemia—Cyclosporine—focal segmental glomerulosclerosis	0.00341	0.00916	CcSEcCtD
Epirubicin—Nail disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00334	0.00897	CcSEcCtD
Epirubicin—ABCC1—cortex of kidney—focal segmental glomerulosclerosis	0.00331	0.0377	CbGeAlD
Epirubicin—Cyst—Cyclosporine—focal segmental glomerulosclerosis	0.00324	0.00871	CcSEcCtD
Epirubicin—Burning sensation—Cyclosporine—focal segmental glomerulosclerosis	0.00312	0.00838	CcSEcCtD
Epirubicin—Thrombosis—Cyclosporine—focal segmental glomerulosclerosis	0.00306	0.00822	CcSEcCtD
Epirubicin—Hyperlipidaemia—Cyclosporine—focal segmental glomerulosclerosis	0.00301	0.00808	CcSEcCtD
Epirubicin—Herpes zoster—Cyclosporine—focal segmental glomerulosclerosis	0.00288	0.00773	CcSEcCtD
Epirubicin—Fungal infection—Cyclosporine—focal segmental glomerulosclerosis	0.00281	0.00754	CcSEcCtD
Epirubicin—Skin ulcer—Cyclosporine—focal segmental glomerulosclerosis	0.00279	0.00748	CcSEcCtD
Epirubicin—Gingivitis—Cyclosporine—focal segmental glomerulosclerosis	0.00276	0.00742	CcSEcCtD
Epirubicin—Hyperaesthesia—Cyclosporine—focal segmental glomerulosclerosis	0.00276	0.00742	CcSEcCtD
Epirubicin—Feeling hot—Cyclosporine—focal segmental glomerulosclerosis	0.00276	0.00742	CcSEcCtD
Epirubicin—Abscess—Cyclosporine—focal segmental glomerulosclerosis	0.00274	0.00736	CcSEcCtD
Epirubicin—Stinging—Cyclosporine—focal segmental glomerulosclerosis	0.00268	0.00718	CcSEcCtD
Epirubicin—Rigors—Cyclosporine—focal segmental glomerulosclerosis	0.00266	0.00713	CcSEcCtD
Epirubicin—Liver injury—Cyclosporine—focal segmental glomerulosclerosis	0.00258	0.00692	CcSEcCtD
Epirubicin—Neoplasm malignant—Cyclosporine—focal segmental glomerulosclerosis	0.00254	0.00682	CcSEcCtD
Epirubicin—Breast pain—Cyclosporine—focal segmental glomerulosclerosis	0.00249	0.00667	CcSEcCtD
Epirubicin—Cardiovascular disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00247	0.00662	CcSEcCtD
Epirubicin—Amenorrhoea—Cyclosporine—focal segmental glomerulosclerosis	0.00247	0.00662	CcSEcCtD
Epirubicin—Viral infection—Cyclosporine—focal segmental glomerulosclerosis	0.0024	0.00644	CcSEcCtD
Epirubicin—Rectal haemorrhage—Cyclosporine—focal segmental glomerulosclerosis	0.0024	0.00644	CcSEcCtD
Epirubicin—Arthropathy—Cyclosporine—focal segmental glomerulosclerosis	0.00238	0.0064	CcSEcCtD
Epirubicin—Cellulitis—Cyclosporine—focal segmental glomerulosclerosis	0.00238	0.0064	CcSEcCtD
Epirubicin—Hyperbilirubinaemia—Cyclosporine—focal segmental glomerulosclerosis	0.00238	0.0064	CcSEcCtD
Epirubicin—Glossitis—Cyclosporine—focal segmental glomerulosclerosis	0.00235	0.00632	CcSEcCtD
Epirubicin—Herpes simplex—Cyclosporine—focal segmental glomerulosclerosis	0.00235	0.00632	CcSEcCtD
Epirubicin—Lacrimation increased—Cyclosporine—focal segmental glomerulosclerosis	0.00235	0.00632	CcSEcCtD
Epirubicin—Nocturia—Cyclosporine—focal segmental glomerulosclerosis	0.00234	0.00627	CcSEcCtD
Epirubicin—Hyperuricaemia—Cyclosporine—focal segmental glomerulosclerosis	0.00234	0.00627	CcSEcCtD
Epirubicin—Creatinine increased—Cyclosporine—focal segmental glomerulosclerosis	0.00228	0.00611	CcSEcCtD
Epirubicin—Blood uric acid increased—Cyclosporine—focal segmental glomerulosclerosis	0.00221	0.00593	CcSEcCtD
Epirubicin—Hepatocellular injury—Cyclosporine—focal segmental glomerulosclerosis	0.00217	0.00582	CcSEcCtD
Epirubicin—Hiccups—Cyclosporine—focal segmental glomerulosclerosis	0.00217	0.00582	CcSEcCtD
Epirubicin—Eructation—Cyclosporine—focal segmental glomerulosclerosis	0.00213	0.00572	CcSEcCtD
Epirubicin—Hyperkalaemia—Cyclosporine—focal segmental glomerulosclerosis	0.00213	0.00572	CcSEcCtD
Epirubicin—Influenza like illness—Cyclosporine—focal segmental glomerulosclerosis	0.00211	0.00565	CcSEcCtD
Epirubicin—Candida infection—Cyclosporine—focal segmental glomerulosclerosis	0.00207	0.00556	CcSEcCtD
Epirubicin—Fluid retention—Cyclosporine—focal segmental glomerulosclerosis	0.00206	0.00553	CcSEcCtD
Epirubicin—Blood urea increased—Cyclosporine—focal segmental glomerulosclerosis	0.00205	0.0055	CcSEcCtD
Epirubicin—Neuropathy—Cyclosporine—focal segmental glomerulosclerosis	0.00204	0.00546	CcSEcCtD
Epirubicin—Cramps of lower extremities—Cyclosporine—focal segmental glomerulosclerosis	0.00199	0.00535	CcSEcCtD
Epirubicin—Coma—Cyclosporine—focal segmental glomerulosclerosis	0.00198	0.00532	CcSEcCtD
Epirubicin—Oesophagitis—Cyclosporine—focal segmental glomerulosclerosis	0.00198	0.00532	CcSEcCtD
Epirubicin—Neoplasm—Cyclosporine—focal segmental glomerulosclerosis	0.00196	0.00526	CcSEcCtD
Epirubicin—Abnormal vision—Cyclosporine—focal segmental glomerulosclerosis	0.00189	0.00508	CcSEcCtD
Epirubicin—Mental disability—Cyclosporine—focal segmental glomerulosclerosis	0.00188	0.00505	CcSEcCtD
Epirubicin—Sepsis—Cyclosporine—focal segmental glomerulosclerosis	0.00188	0.00505	CcSEcCtD
Epirubicin—Lymphadenopathy—Cyclosporine—focal segmental glomerulosclerosis	0.00185	0.00495	CcSEcCtD
Epirubicin—Diabetes mellitus—Cyclosporine—focal segmental glomerulosclerosis	0.00181	0.00486	CcSEcCtD
Epirubicin—Hepatic function abnormal—Cyclosporine—focal segmental glomerulosclerosis	0.0018	0.00483	CcSEcCtD
Epirubicin—Vascular purpura—Cyclosporine—focal segmental glomerulosclerosis	0.00176	0.00472	CcSEcCtD
Epirubicin—Eczema—Cyclosporine—focal segmental glomerulosclerosis	0.00175	0.0047	CcSEcCtD
Epirubicin—Hepatic failure—Cyclosporine—focal segmental glomerulosclerosis	0.00175	0.0047	CcSEcCtD
Epirubicin—Eye pain—Cyclosporine—focal segmental glomerulosclerosis	0.00174	0.00468	CcSEcCtD
Epirubicin—Hot flush—Cyclosporine—focal segmental glomerulosclerosis	0.00168	0.00452	CcSEcCtD
Epirubicin—Increased appetite—Cyclosporine—focal segmental glomerulosclerosis	0.00168	0.0045	CcSEcCtD
Epirubicin—Menopausal symptoms—Cyclosporine—focal segmental glomerulosclerosis	0.00167	0.00448	CcSEcCtD
Epirubicin—Renal impairment—Cyclosporine—focal segmental glomerulosclerosis	0.00165	0.00444	CcSEcCtD
Epirubicin—Dermatitis bullous—Cyclosporine—focal segmental glomerulosclerosis	0.00165	0.00442	CcSEcCtD
Epirubicin—Purpura—Cyclosporine—focal segmental glomerulosclerosis	0.00163	0.00438	CcSEcCtD
Epirubicin—Anaphylactoid reaction—Cyclosporine—focal segmental glomerulosclerosis	0.00163	0.00437	CcSEcCtD
Epirubicin—Hypoglycaemia—Cyclosporine—focal segmental glomerulosclerosis	0.00161	0.00433	CcSEcCtD
Epirubicin—Cardiac failure—Cyclosporine—focal segmental glomerulosclerosis	0.00161	0.00433	CcSEcCtD
Epirubicin—Lethargy—Cyclosporine—focal segmental glomerulosclerosis	0.00161	0.00431	CcSEcCtD
Epirubicin—Osteoarthritis—Cyclosporine—focal segmental glomerulosclerosis	0.00157	0.00423	CcSEcCtD
Epirubicin—Affect lability—Cyclosporine—focal segmental glomerulosclerosis	0.00155	0.00416	CcSEcCtD
Epirubicin—Migraine—Cyclosporine—focal segmental glomerulosclerosis	0.00155	0.00416	CcSEcCtD
Epirubicin—Mood swings—Cyclosporine—focal segmental glomerulosclerosis	0.00149	0.004	CcSEcCtD
Epirubicin—Blood creatinine increased—Cyclosporine—focal segmental glomerulosclerosis	0.00147	0.00396	CcSEcCtD
Epirubicin—Dry skin—Cyclosporine—focal segmental glomerulosclerosis	0.00144	0.00387	CcSEcCtD
Epirubicin—Abdominal pain upper—Cyclosporine—focal segmental glomerulosclerosis	0.00144	0.00386	CcSEcCtD
Epirubicin—Breast disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00142	0.00382	CcSEcCtD
Epirubicin—Gastritis—Cyclosporine—focal segmental glomerulosclerosis	0.00139	0.00374	CcSEcCtD
Epirubicin—Muscular weakness—Cyclosporine—focal segmental glomerulosclerosis	0.00139	0.00373	CcSEcCtD
Epirubicin—Abdominal distension—Cyclosporine—focal segmental glomerulosclerosis	0.00137	0.00368	CcSEcCtD
Epirubicin—Dysphagia—Cyclosporine—focal segmental glomerulosclerosis	0.00136	0.00365	CcSEcCtD
Epirubicin—YWHAG—PDGFR-beta signaling pathway—ACTA2—focal segmental glomerulosclerosis	0.00135	0.0477	CbGpPWpGaD
Epirubicin—Pancreatitis—Cyclosporine—focal segmental glomerulosclerosis	0.00133	0.00358	CcSEcCtD
Epirubicin—Bronchitis—Cyclosporine—focal segmental glomerulosclerosis	0.00131	0.00351	CcSEcCtD
Epirubicin—YWHAG—PDGFR-beta signaling pathway—ACTN4—focal segmental glomerulosclerosis	0.0013	0.046	CbGpPWpGaD
Epirubicin—Dysuria—Cyclosporine—focal segmental glomerulosclerosis	0.00127	0.00341	CcSEcCtD
Epirubicin—Upper respiratory tract infection—Cyclosporine—focal segmental glomerulosclerosis	0.00126	0.00339	CcSEcCtD
Epirubicin—Pollakiuria—Cyclosporine—focal segmental glomerulosclerosis	0.00126	0.00337	CcSEcCtD
Epirubicin—AURKA—Integrated Breast Cancer Pathway—PIAS1—focal segmental glomerulosclerosis	0.00124	0.0438	CbGpPWpGaD
Epirubicin—Weight increased—Cyclosporine—focal segmental glomerulosclerosis	0.00124	0.00332	CcSEcCtD
Epirubicin—Weight decreased—Cyclosporine—focal segmental glomerulosclerosis	0.00123	0.0033	CcSEcCtD
Epirubicin—Hyperglycaemia—Cyclosporine—focal segmental glomerulosclerosis	0.00123	0.00329	CcSEcCtD
Epirubicin—Pneumonia—Cyclosporine—focal segmental glomerulosclerosis	0.00122	0.00327	CcSEcCtD
Epirubicin—Infestation NOS—Cyclosporine—focal segmental glomerulosclerosis	0.00121	0.00326	CcSEcCtD
Epirubicin—Infestation—Cyclosporine—focal segmental glomerulosclerosis	0.00121	0.00326	CcSEcCtD
Epirubicin—Renal failure—Cyclosporine—focal segmental glomerulosclerosis	0.00119	0.0032	CcSEcCtD
Epirubicin—Neuropathy peripheral—Cyclosporine—focal segmental glomerulosclerosis	0.00119	0.00319	CcSEcCtD
Epirubicin—Stomatitis—Cyclosporine—focal segmental glomerulosclerosis	0.00118	0.00317	CcSEcCtD
Epirubicin—Jaundice—Cyclosporine—focal segmental glomerulosclerosis	0.00118	0.00317	CcSEcCtD
Epirubicin—Conjunctivitis—Cyclosporine—focal segmental glomerulosclerosis	0.00118	0.00316	CcSEcCtD
Epirubicin—Urinary tract infection—Cyclosporine—focal segmental glomerulosclerosis	0.00118	0.00316	CcSEcCtD
Epirubicin—Haematuria—Cyclosporine—focal segmental glomerulosclerosis	0.00116	0.0031	CcSEcCtD
Epirubicin—Hepatobiliary disease—Cyclosporine—focal segmental glomerulosclerosis	0.00115	0.00308	CcSEcCtD
Epirubicin—PLA2G4A—ADP signalling through P2Y purinoceptor 1—GNAQ—focal segmental glomerulosclerosis	0.00115	0.0405	CbGpPWpGaD
Epirubicin—Epistaxis—Cyclosporine—focal segmental glomerulosclerosis	0.00114	0.00307	CcSEcCtD
Epirubicin—Sinusitis—Cyclosporine—focal segmental glomerulosclerosis	0.00114	0.00305	CcSEcCtD
Epirubicin—YWHAG—Myometrial Relaxation and Contraction Pathways—ACTA2—focal segmental glomerulosclerosis	0.00114	0.0402	CbGpPWpGaD
Epirubicin—Haemoglobin—Cyclosporine—focal segmental glomerulosclerosis	0.00109	0.00294	CcSEcCtD
Epirubicin—Rhinitis—Cyclosporine—focal segmental glomerulosclerosis	0.00109	0.00293	CcSEcCtD
Epirubicin—Hepatitis—Cyclosporine—focal segmental glomerulosclerosis	0.00109	0.00292	CcSEcCtD
Epirubicin—Haemorrhage—Cyclosporine—focal segmental glomerulosclerosis	0.00109	0.00292	CcSEcCtD
Epirubicin—Hypoaesthesia—Cyclosporine—focal segmental glomerulosclerosis	0.00108	0.00291	CcSEcCtD
Epirubicin—Pharyngitis—Cyclosporine—focal segmental glomerulosclerosis	0.00108	0.0029	CcSEcCtD
Epirubicin—Urinary tract disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00108	0.00289	CcSEcCtD
Epirubicin—Connective tissue disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00107	0.00287	CcSEcCtD
Epirubicin—Urethral disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00107	0.00287	CcSEcCtD
Epirubicin—ABCC1—Sphingosine 1-phosphate (S1P) pathway—GNAQ—focal segmental glomerulosclerosis	0.00105	0.0372	CbGpPWpGaD
Epirubicin—Visual impairment—Cyclosporine—focal segmental glomerulosclerosis	0.00105	0.00282	CcSEcCtD
Epirubicin—Tinnitus—Cyclosporine—focal segmental glomerulosclerosis	0.00102	0.00273	CcSEcCtD
Epirubicin—Flushing—Cyclosporine—focal segmental glomerulosclerosis	0.00101	0.00271	CcSEcCtD
Epirubicin—Angiopathy—Cyclosporine—focal segmental glomerulosclerosis	0.000988	0.00265	CcSEcCtD
Epirubicin—Mediastinal disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000981	0.00263	CcSEcCtD
Epirubicin—Chills—Cyclosporine—focal segmental glomerulosclerosis	0.000977	0.00262	CcSEcCtD
Epirubicin—Arrhythmia—Cyclosporine—focal segmental glomerulosclerosis	0.000973	0.00261	CcSEcCtD
Epirubicin—PLA2G4A—Signal amplification—GNAQ—focal segmental glomerulosclerosis	0.000964	0.0341	CbGpPWpGaD
Epirubicin—Alopecia—Cyclosporine—focal segmental glomerulosclerosis	0.000962	0.00258	CcSEcCtD
Epirubicin—Mental disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000954	0.00256	CcSEcCtD
Epirubicin—Malnutrition—Cyclosporine—focal segmental glomerulosclerosis	0.000948	0.00254	CcSEcCtD
Epirubicin—Flatulence—Cyclosporine—focal segmental glomerulosclerosis	0.000934	0.00251	CcSEcCtD
Epirubicin—Tension—Cyclosporine—focal segmental glomerulosclerosis	0.00093	0.0025	CcSEcCtD
Epirubicin—Dysgeusia—Cyclosporine—focal segmental glomerulosclerosis	0.000928	0.00249	CcSEcCtD
Epirubicin—TOP2A—G0 and Early G1—PCNA—focal segmental glomerulosclerosis	0.000925	0.0327	CbGpPWpGaD
Epirubicin—Nervousness—Cyclosporine—focal segmental glomerulosclerosis	0.000921	0.00247	CcSEcCtD
Epirubicin—Muscle spasms—Cyclosporine—focal segmental glomerulosclerosis	0.000911	0.00245	CcSEcCtD
Epirubicin—Vision blurred—Cyclosporine—focal segmental glomerulosclerosis	0.000893	0.0024	CcSEcCtD
Epirubicin—Ill-defined disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00088	0.00236	CcSEcCtD
Epirubicin—Anaemia—Cyclosporine—focal segmental glomerulosclerosis	0.000876	0.00235	CcSEcCtD
Epirubicin—Agitation—Cyclosporine—focal segmental glomerulosclerosis	0.000871	0.00234	CcSEcCtD
Epirubicin—Malaise—Cyclosporine—focal segmental glomerulosclerosis	0.000855	0.00229	CcSEcCtD
Epirubicin—Vertigo—Cyclosporine—focal segmental glomerulosclerosis	0.000852	0.00229	CcSEcCtD
Epirubicin—Leukopenia—Cyclosporine—focal segmental glomerulosclerosis	0.000849	0.00228	CcSEcCtD
Epirubicin—Cough—Cyclosporine—focal segmental glomerulosclerosis	0.000827	0.00222	CcSEcCtD
Epirubicin—Convulsion—Cyclosporine—focal segmental glomerulosclerosis	0.000821	0.0022	CcSEcCtD
Epirubicin—PLA2G4A—PDGFR-beta signaling pathway—ACTA2—focal segmental glomerulosclerosis	0.000819	0.0289	CbGpPWpGaD
Epirubicin—Hypertension—Cyclosporine—focal segmental glomerulosclerosis	0.000818	0.0022	CcSEcCtD
Epirubicin—Arthralgia—Cyclosporine—focal segmental glomerulosclerosis	0.000807	0.00217	CcSEcCtD
Epirubicin—Chest pain—Cyclosporine—focal segmental glomerulosclerosis	0.000807	0.00217	CcSEcCtD
Epirubicin—Myalgia—Cyclosporine—focal segmental glomerulosclerosis	0.000807	0.00217	CcSEcCtD
Epirubicin—Anxiety—Cyclosporine—focal segmental glomerulosclerosis	0.000804	0.00216	CcSEcCtD
Epirubicin—Unspecified disorder of skin and subcutaneous tissue—Cyclosporine—focal segmental glomerulosclerosis	0.000802	0.00215	CcSEcCtD
Epirubicin—Discomfort—Cyclosporine—focal segmental glomerulosclerosis	0.000797	0.00214	CcSEcCtD
Epirubicin—Dry mouth—Cyclosporine—focal segmental glomerulosclerosis	0.000789	0.00212	CcSEcCtD
Epirubicin—PLA2G4A—PDGFR-beta signaling pathway—ACTN4—focal segmental glomerulosclerosis	0.000788	0.0278	CbGpPWpGaD
Epirubicin—Confusional state—Cyclosporine—focal segmental glomerulosclerosis	0.00078	0.00209	CcSEcCtD
Epirubicin—Oedema—Cyclosporine—focal segmental glomerulosclerosis	0.000774	0.00208	CcSEcCtD
Epirubicin—Anaphylactic shock—Cyclosporine—focal segmental glomerulosclerosis	0.000774	0.00208	CcSEcCtD
Epirubicin—Infection—Cyclosporine—focal segmental glomerulosclerosis	0.000769	0.00206	CcSEcCtD
Epirubicin—PLA2G4A—Prostaglandin Synthesis and Regulation—EDN1—focal segmental glomerulosclerosis	0.000768	0.0271	CbGpPWpGaD
Epirubicin—Nervous system disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000759	0.00204	CcSEcCtD
Epirubicin—Thrombocytopenia—Cyclosporine—focal segmental glomerulosclerosis	0.000758	0.00203	CcSEcCtD
Epirubicin—Skin disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000751	0.00202	CcSEcCtD
Epirubicin—Hyperhidrosis—Cyclosporine—focal segmental glomerulosclerosis	0.000748	0.00201	CcSEcCtD
Epirubicin—Anorexia—Cyclosporine—focal segmental glomerulosclerosis	0.000737	0.00198	CcSEcCtD
Epirubicin—Musculoskeletal discomfort—Cyclosporine—focal segmental glomerulosclerosis	0.000705	0.00189	CcSEcCtD
Epirubicin—Insomnia—Cyclosporine—focal segmental glomerulosclerosis	0.0007	0.00188	CcSEcCtD
Epirubicin—Paraesthesia—Cyclosporine—focal segmental glomerulosclerosis	0.000695	0.00186	CcSEcCtD
Epirubicin—Dyspnoea—Cyclosporine—focal segmental glomerulosclerosis	0.00069	0.00185	CcSEcCtD
Epirubicin—Somnolence—Cyclosporine—focal segmental glomerulosclerosis	0.000688	0.00185	CcSEcCtD
Epirubicin—Dyspepsia—Cyclosporine—focal segmental glomerulosclerosis	0.000681	0.00183	CcSEcCtD
Epirubicin—Decreased appetite—Cyclosporine—focal segmental glomerulosclerosis	0.000673	0.00181	CcSEcCtD
Epirubicin—Gastrointestinal disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000668	0.00179	CcSEcCtD
Epirubicin—Fatigue—Cyclosporine—focal segmental glomerulosclerosis	0.000667	0.00179	CcSEcCtD
Epirubicin—Constipation—Cyclosporine—focal segmental glomerulosclerosis	0.000662	0.00178	CcSEcCtD
Epirubicin—Pain—Cyclosporine—focal segmental glomerulosclerosis	0.000662	0.00178	CcSEcCtD
Epirubicin—PLA2G4A—Endothelins—TRPC6—focal segmental glomerulosclerosis	0.000654	0.0231	CbGpPWpGaD
Epirubicin—Feeling abnormal—Cyclosporine—focal segmental glomerulosclerosis	0.000638	0.00171	CcSEcCtD
Epirubicin—Gastrointestinal pain—Cyclosporine—focal segmental glomerulosclerosis	0.000633	0.0017	CcSEcCtD
Epirubicin—Urticaria—Cyclosporine—focal segmental glomerulosclerosis	0.000615	0.00165	CcSEcCtD
Epirubicin—Abdominal pain—Cyclosporine—focal segmental glomerulosclerosis	0.000612	0.00164	CcSEcCtD
Epirubicin—Body temperature increased—Cyclosporine—focal segmental glomerulosclerosis	0.000612	0.00164	CcSEcCtD
Epirubicin—Hypersensitivity—Cyclosporine—focal segmental glomerulosclerosis	0.00057	0.00153	CcSEcCtD
Epirubicin—Asthenia—Cyclosporine—focal segmental glomerulosclerosis	0.000555	0.00149	CcSEcCtD
Epirubicin—PLA2G4A—Platelet homeostasis—TRPC6—focal segmental glomerulosclerosis	0.000551	0.0195	CbGpPWpGaD
Epirubicin—Pruritus—Cyclosporine—focal segmental glomerulosclerosis	0.000547	0.00147	CcSEcCtD
Epirubicin—PLA2G4A—Endothelins—GNAQ—focal segmental glomerulosclerosis	0.000547	0.0193	CbGpPWpGaD
Epirubicin—TOP2A—Integrated Pancreatic Cancer Pathway—PIAS1—focal segmental glomerulosclerosis	0.000545	0.0192	CbGpPWpGaD
Epirubicin—Diarrhoea—Cyclosporine—focal segmental glomerulosclerosis	0.000529	0.00142	CcSEcCtD
Epirubicin—PLA2G4A—Signaling mediated by p38-alpha and p38-beta—NOS2—focal segmental glomerulosclerosis	0.000514	0.0182	CbGpPWpGaD
Epirubicin—Dizziness—Cyclosporine—focal segmental glomerulosclerosis	0.000512	0.00137	CcSEcCtD
Epirubicin—PLA2G4A—Platelet activation, signaling and aggregation—ACTN4—focal segmental glomerulosclerosis	0.0005	0.0176	CbGpPWpGaD
Epirubicin—Vomiting—Cyclosporine—focal segmental glomerulosclerosis	0.000492	0.00132	CcSEcCtD
Epirubicin—Rash—Cyclosporine—focal segmental glomerulosclerosis	0.000488	0.00131	CcSEcCtD
Epirubicin—Dermatitis—Cyclosporine—focal segmental glomerulosclerosis	0.000487	0.00131	CcSEcCtD
Epirubicin—Headache—Cyclosporine—focal segmental glomerulosclerosis	0.000485	0.0013	CcSEcCtD
Epirubicin—PLA2G4A—Integrated Pancreatic Cancer Pathway—PIAS1—focal segmental glomerulosclerosis	0.000472	0.0167	CbGpPWpGaD
Epirubicin—Nausea—Cyclosporine—focal segmental glomerulosclerosis	0.00046	0.00123	CcSEcCtD
Epirubicin—YWHAG—Calcium Regulation in the Cardiac Cell—GNAQ—focal segmental glomerulosclerosis	0.000453	0.016	CbGpPWpGaD
Epirubicin—YWHAG—Myometrial Relaxation and Contraction Pathways—GNAQ—focal segmental glomerulosclerosis	0.000439	0.0155	CbGpPWpGaD
Epirubicin—YWHAG—Cell Cycle—PCNA—focal segmental glomerulosclerosis	0.000429	0.0152	CbGpPWpGaD
Epirubicin—PLA2G4A—Endothelins—EDN1—focal segmental glomerulosclerosis	0.000424	0.015	CbGpPWpGaD
Epirubicin—AURKA—EGF/EGFR Signaling Pathway—PCNA—focal segmental glomerulosclerosis	0.000391	0.0138	CbGpPWpGaD
Epirubicin—YWHAG—Regulation of nuclear beta catenin signaling and target gene transcription—MMP2—focal segmental glomerulosclerosis	0.000376	0.0133	CbGpPWpGaD
Epirubicin—TOP2A—Integrated Pancreatic Cancer Pathway—WT1—focal segmental glomerulosclerosis	0.00036	0.0127	CbGpPWpGaD
Epirubicin—DHCR7—Metabolism of lipids and lipoproteins—LIPC—focal segmental glomerulosclerosis	0.000342	0.0121	CbGpPWpGaD
Epirubicin—TOP2A—Retinoblastoma (RB) in Cancer—PCNA—focal segmental glomerulosclerosis	0.000341	0.012	CbGpPWpGaD
Epirubicin—PLA2G4A—Integrated Pancreatic Cancer Pathway—WT1—focal segmental glomerulosclerosis	0.000311	0.011	CbGpPWpGaD
Epirubicin—PLA2G4A—AGE/RAGE pathway—NOS2—focal segmental glomerulosclerosis	0.00031	0.0109	CbGpPWpGaD
Epirubicin—DHCR7—Metabolism of lipids and lipoproteins—CTGF—focal segmental glomerulosclerosis	0.000302	0.0106	CbGpPWpGaD
Epirubicin—YWHAG—Regulation of nuclear beta catenin signaling and target gene transcription—MMP9—focal segmental glomerulosclerosis	0.000283	0.00998	CbGpPWpGaD
Epirubicin—PLA2G4A—Platelet homeostasis—NOS2—focal segmental glomerulosclerosis	0.000271	0.00957	CbGpPWpGaD
Epirubicin—PLA2G4A—AGE/RAGE pathway—MMP2—focal segmental glomerulosclerosis	0.000266	0.00939	CbGpPWpGaD
Epirubicin—PLA2G4A—Hemostasis—ACTN4—focal segmental glomerulosclerosis	0.000258	0.0091	CbGpPWpGaD
Epirubicin—TOP2A—Circadian rythm related genes—GNAQ—focal segmental glomerulosclerosis	0.00025	0.00882	CbGpPWpGaD
Epirubicin—TOP2A—Mitotic G1-G1/S phases—PCNA—focal segmental glomerulosclerosis	0.00024	0.00848	CbGpPWpGaD
Epirubicin—PLA2G4A—Platelet activation, signaling and aggregation—TRPC6—focal segmental glomerulosclerosis	0.00024	0.00847	CbGpPWpGaD
Epirubicin—DHCR7—Metabolism of lipids and lipoproteins—LPL—focal segmental glomerulosclerosis	0.000209	0.00738	CbGpPWpGaD
Epirubicin—PLA2G4A—Platelet activation, signaling and aggregation—GNAQ—focal segmental glomerulosclerosis	0.0002	0.00708	CbGpPWpGaD
Epirubicin—PLA2G4A—AGE/RAGE pathway—MMP9—focal segmental glomerulosclerosis	0.0002	0.00705	CbGpPWpGaD
Epirubicin—YWHAG—Cell Cycle—TGFB1—focal segmental glomerulosclerosis	0.000192	0.00677	CbGpPWpGaD
Epirubicin—TOP2A—Integrated Pancreatic Cancer Pathway—PCNA—focal segmental glomerulosclerosis	0.000182	0.00642	CbGpPWpGaD
Epirubicin—DHCR7—Metabolism of lipids and lipoproteins—AGT—focal segmental glomerulosclerosis	0.000179	0.00632	CbGpPWpGaD
Epirubicin—PLA2G4A—Hemostasis—ANGPT2—focal segmental glomerulosclerosis	0.000172	0.00609	CbGpPWpGaD
Epirubicin—AURKA—Cell Cycle, Mitotic—PCNA—focal segmental glomerulosclerosis	0.000166	0.00587	CbGpPWpGaD
Epirubicin—PLA2G4A—Integrated Pancreatic Cancer Pathway—PCNA—focal segmental glomerulosclerosis	0.000158	0.00556	CbGpPWpGaD
Epirubicin—DHCR7—Metabolism—LIPC—focal segmental glomerulosclerosis	0.000153	0.00539	CbGpPWpGaD
Epirubicin—AURKA—Cell Cycle—PCNA—focal segmental glomerulosclerosis	0.000148	0.00524	CbGpPWpGaD
Epirubicin—TOP2A—Circadian rythm related genes—NOS2—focal segmental glomerulosclerosis	0.000147	0.00518	CbGpPWpGaD
Epirubicin—DHCR7—Metabolism of lipids and lipoproteins—ALB—focal segmental glomerulosclerosis	0.000137	0.00485	CbGpPWpGaD
Epirubicin—DHCR7—Metabolism—CTGF—focal segmental glomerulosclerosis	0.000134	0.00474	CbGpPWpGaD
Epirubicin—YWHAG—Cell Cycle, Mitotic—PCNA—focal segmental glomerulosclerosis	0.000126	0.00445	CbGpPWpGaD
Epirubicin—DHCR7—Metabolism—GNAQ—focal segmental glomerulosclerosis	0.000124	0.00437	CbGpPWpGaD
Epirubicin—PLA2G4A—Hemostasis—TRPC6—focal segmental glomerulosclerosis	0.000124	0.00436	CbGpPWpGaD
Epirubicin—TOP2A—Circadian rythm related genes—SERPINE1—focal segmental glomerulosclerosis	0.000123	0.00436	CbGpPWpGaD
Epirubicin—PLA2G4A—Platelet activation, signaling and aggregation—FN1—focal segmental glomerulosclerosis	0.000119	0.00421	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism of lipids and lipoproteins—LIPC—focal segmental glomerulosclerosis	0.000116	0.00409	CbGpPWpGaD
Epirubicin—YWHAG—Cell Cycle—PCNA—focal segmental glomerulosclerosis	0.000113	0.00397	CbGpPWpGaD
Epirubicin—PLA2G4A—Hemostasis—GNAQ—focal segmental glomerulosclerosis	0.000103	0.00365	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism of lipids and lipoproteins—CTGF—focal segmental glomerulosclerosis	0.000102	0.00361	CbGpPWpGaD
Epirubicin—PLA2G4A—Platelet activation, signaling and aggregation—SERPINE1—focal segmental glomerulosclerosis	9.92e-05	0.0035	CbGpPWpGaD
Epirubicin—PLA2G4A—Platelet activation, signaling and aggregation—ALB—focal segmental glomerulosclerosis	9.9e-05	0.0035	CbGpPWpGaD
Epirubicin—DHCR7—Metabolism—LPL—focal segmental glomerulosclerosis	9.31e-05	0.00329	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism of lipids and lipoproteins—LIPC—focal segmental glomerulosclerosis	9.26e-05	0.00327	CbGpPWpGaD
Epirubicin—UGT2B7—NRF2 pathway—TGFB1—focal segmental glomerulosclerosis	8.89e-05	0.00314	CbGpPWpGaD
Epirubicin—TOP2A—Cell Cycle, Mitotic—PCNA—focal segmental glomerulosclerosis	8.8e-05	0.00311	CbGpPWpGaD
Epirubicin—ABCC1—Transmembrane transport of small molecules—TRPC6—focal segmental glomerulosclerosis	8.55e-05	0.00302	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism of lipids and lipoproteins—CTGF—focal segmental glomerulosclerosis	8.15e-05	0.00288	CbGpPWpGaD
Epirubicin—TOP2A—Integrated Pancreatic Cancer Pathway—TGFB1—focal segmental glomerulosclerosis	8.12e-05	0.00287	CbGpPWpGaD
Epirubicin—DHCR7—Metabolism—AGT—focal segmental glomerulosclerosis	7.96e-05	0.00281	CbGpPWpGaD
Epirubicin—TOP2A—Cell Cycle—PCNA—focal segmental glomerulosclerosis	7.87e-05	0.00278	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—COL4A4—focal segmental glomerulosclerosis	7.34e-05	0.00259	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—TRPC6—focal segmental glomerulosclerosis	7.09e-05	0.0025	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism of lipids and lipoproteins—LPL—focal segmental glomerulosclerosis	7.07e-05	0.0025	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—AGTR2—focal segmental glomerulosclerosis	7.05e-05	0.00249	CbGpPWpGaD
Epirubicin—PLA2G4A—Integrated Pancreatic Cancer Pathway—TGFB1—focal segmental glomerulosclerosis	7.03e-05	0.00248	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—COL4A1—focal segmental glomerulosclerosis	6.74e-05	0.00238	CbGpPWpGaD
Epirubicin—PLA2G4A—Platelet activation, signaling and aggregation—TGFB1—focal segmental glomerulosclerosis	6.26e-05	0.00221	CbGpPWpGaD
Epirubicin—PLA2G4A—Hemostasis—FN1—focal segmental glomerulosclerosis	6.14e-05	0.00217	CbGpPWpGaD
Epirubicin—DHCR7—Metabolism—ALB—focal segmental glomerulosclerosis	6.11e-05	0.00216	CbGpPWpGaD
Epirubicin—PLA2G4A—Hemostasis—NOS2—focal segmental glomerulosclerosis	6.07e-05	0.00214	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism of lipids and lipoproteins—AGT—focal segmental glomerulosclerosis	6.05e-05	0.00214	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—GNAQ—focal segmental glomerulosclerosis	5.93e-05	0.00209	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—COL4A3—focal segmental glomerulosclerosis	5.7e-05	0.00201	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism of lipids and lipoproteins—LPL—focal segmental glomerulosclerosis	5.65e-05	0.002	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—AGTR1—focal segmental glomerulosclerosis	5.42e-05	0.00192	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—LIPC—focal segmental glomerulosclerosis	5.26e-05	0.00186	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—LIPC—focal segmental glomerulosclerosis	5.16e-05	0.00182	CbGpPWpGaD
Epirubicin—PLA2G4A—Hemostasis—SERPINE1—focal segmental glomerulosclerosis	5.11e-05	0.00181	CbGpPWpGaD
Epirubicin—PLA2G4A—Hemostasis—ALB—focal segmental glomerulosclerosis	5.1e-05	0.0018	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism of lipids and lipoproteins—AGT—focal segmental glomerulosclerosis	4.84e-05	0.00171	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism of lipids and lipoproteins—ALB—focal segmental glomerulosclerosis	4.64e-05	0.00164	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—CTGF—focal segmental glomerulosclerosis	4.63e-05	0.00164	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—EDN1—focal segmental glomerulosclerosis	4.6e-05	0.00162	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—CTGF—focal segmental glomerulosclerosis	4.55e-05	0.00161	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—GNAQ—focal segmental glomerulosclerosis	4.27e-05	0.00151	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	4.19e-05	0.00148	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—GNAQ—focal segmental glomerulosclerosis	4.19e-05	0.00148	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	4.17e-05	0.00147	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—LIPC—focal segmental glomerulosclerosis	4.13e-05	0.00146	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	3.82e-05	0.00135	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism of lipids and lipoproteins—ALB—focal segmental glomerulosclerosis	3.71e-05	0.00131	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—CTGF—focal segmental glomerulosclerosis	3.63e-05	0.00128	CbGpPWpGaD
Epirubicin—ABCC1—Transmembrane transport of small molecules—ALB—focal segmental glomerulosclerosis	3.53e-05	0.00125	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	3.5e-05	0.00124	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—GNAQ—focal segmental glomerulosclerosis	3.35e-05	0.00118	CbGpPWpGaD
Epirubicin—PLA2G4A—Hemostasis—TGFB1—focal segmental glomerulosclerosis	3.23e-05	0.00114	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—LPL—focal segmental glomerulosclerosis	3.21e-05	0.00113	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	3.2e-05	0.00113	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—LPL—focal segmental glomerulosclerosis	3.15e-05	0.00111	CbGpPWpGaD
Epirubicin—ABCC1—Disease—LPL—focal segmental glomerulosclerosis	3.01e-05	0.00106	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—AGT—focal segmental glomerulosclerosis	2.75e-05	0.000971	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	2.72e-05	0.000959	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—AGT—focal segmental glomerulosclerosis	2.7e-05	0.000952	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—LPL—focal segmental glomerulosclerosis	2.63e-05	0.000931	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—LPL—focal segmental glomerulosclerosis	2.52e-05	0.000889	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	2.5e-05	0.000881	CbGpPWpGaD
Epirubicin—ABCC1—Disease—NOS2—focal segmental glomerulosclerosis	2.35e-05	0.000829	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—AGT—focal segmental glomerulosclerosis	2.25e-05	0.000796	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—AGT—focal segmental glomerulosclerosis	2.15e-05	0.000761	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—ALB—focal segmental glomerulosclerosis	2.11e-05	0.000745	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—FN1—focal segmental glomerulosclerosis	2.08e-05	0.000736	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—ALB—focal segmental glomerulosclerosis	2.07e-05	0.000731	CbGpPWpGaD
Epirubicin—ABCC1—Disease—SERPINE1—focal segmental glomerulosclerosis	1.98e-05	0.000698	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	1.73e-05	0.000612	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—ALB—focal segmental glomerulosclerosis	1.65e-05	0.000584	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	1.33e-05	0.000469	CbGpPWpGaD
Epirubicin—ABCC1—Disease—TGFB1—focal segmental glomerulosclerosis	1.25e-05	0.000441	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	1.09e-05	0.000386	CbGpPWpGaD
